44 /100
MEDIUM RISK
Score updated Jul 13, 2026

HOWL — Werewolf Therapeutics, Inc. Dilution Risk Tracker

Track HOWL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HOWL — Get alerts when the score changes →

As of July 13, 2026, Werewolf Therapeutics, Inc. (HOWL) has a DilutionWatch DilutionScore of 44/100, rated MEDIUM dilution risk. Werewolf Therapeutics, Inc. has a market capitalization of $21.87M, 48.60M shares outstanding, 49 institutional holders tracked. Key dilution vectors include approximately 10 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
37%
🔄 Reverse Split 65%
• 50-day avg $0.74 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (10mo)
🔔 Track HOWL — Get forecast alerts →

💹 Market Data

Market Cap$21.87M
Shares Outstanding48.60M
Float41.23M
Cash$46.45M
Debt$32.09M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 6.1% shares (2026Q1 vs prior)
49 institutional holders · 15.57M shares
#1 RA CAPITAL MANAGEMENT, L.P. 6.68M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.44M shares
#3 MPM BIOIMPACT LLC 1.21M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest847.1K
Days to Cover1.0
% of Float2.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for HOWL Shareholders

Werewolf Therapeutics, Inc. (HOWL) has a DilutionScore of 44/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

Cash runway is a key watch item: HOWL has approximately 10 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for HOWL in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HOWL alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HOWL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HOWL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH AHRT ALOT AMPH

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HOWL
📊 HOWL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HOWL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.